Upgrade to SI Premium - Free Trial

TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

August 31, 2026 9:03 AM
TD Cowen analyst Ritu Baral reiterated a Buy rating and $482.00 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments